Overview

Sustained Release Lidocaine for the Treatment of Postoperative Pain

Status:
Recruiting
Trial end date:
2023-05-27
Target enrollment:
0
Participant gender:
All
Summary
In this study, the investigators are testing a new formulation of lidocaine for its suitability in managing postoperative pain after pelvic surgery. The new formulation ST-01 is a sustained release lidocaine formulation and is expected to provide pain relief over multiple days. Currently, the drug lidocaine is not available as an injectable slow-release formulation.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of British Columbia
Treatments:
Bupivacaine
Lidocaine
Criteria
Inclusion Criteria:

- Any sex, aged ≥ 19 years

- Indication to undergo an operation with a planned pelvic incision

- Able and willing to provide informed consent

- Stated willingness to comply with all study procedures and availability for the
duration of the study

- If sexually active, is willing to use adequate birth control methods to prevent
pregnancy over the course of the study

Exclusion Criteria:

- History of chronic pain conditions associated with the use of opioids or steroids

- Known allergic reactions to any components of the investigational product

- Active infection involving the surgical site

- Any contraindication to local anesthesia with lidocaine (e.g., known hypersensitivity
to anesthetics of the amide type, known hypokalemia, complete heart block,
anticoagulants (ASA permitted) antiarrhythmic medication)

- Use of prohibited medications (quinidine, procainamide, disopyramide, lidocaine,
mexiletine, flecainide, propafenone, amiodarone, dronedarone, ibutilide, dofetilide,
sotalol, vernakalant)

- Has participated in another clinical trial within 3 months prior to the Screening
Visit or is planning to participate in another clinical trial during this trial period

- Has any other surgical or medical condition that, in the judgment of the clinical
Investigator might warrant exclusion or be contraindicated for safety reason